Health insurance provider Elevance Health (NYSE:ELV) reported revenue ahead of Wall Street’s expectations in Q3 2026, but sales were flat year on year at $50.44 billion. Its non-GAAP profit of $6.99 ...
Trailing total returns as of 10/22/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) Return EEENF S&P/ASX 200 [XJO] (^AXJO) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results